Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Neoplasms of the CNS

  Free Subscription


Articles published in Br J Cancer

Retrieve available abstracts of 25 articles:
HTML format
Text format



Single Articles


    November 2018
  1. WANG S, O'Rourke DM, Chawla S, Verma G, et al
    Multiparametric magnetic resonance imaging in the assessment of anti-EGFRvIII chimeric antigen receptor T cell therapy in patients with recurrent glioblastoma.
    Br J Cancer. 2018 Nov 27. pii: 10.1038/s41416-018-0342.
    PubMed     Text format     Abstract available


  2. BROWN NF, Carter TJ, Ottaviani D, Mulholland P, et al
    Harnessing the immune system in glioblastoma.
    Br J Cancer. 2018 Nov 5. pii: 10.1038/s41416-018-0258.
    PubMed     Text format     Abstract available


    September 2018
  3. ZIEGLER DS, Wong M, Mayoh C, Kumar A, et al
    Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma.
    Br J Cancer. 2018 Sep 17. pii: 10.1038/s41416-018-0251.
    PubMed     Text format     Abstract available


    August 2018
  4. KROL I, Castro-Giner F, Maurer M, Gkountela S, et al
    Detection of circulating tumour cell clusters in human glioblastoma.
    Br J Cancer. 2018 Aug 1. pii: 10.1038/s41416-018-0186.
    PubMed     Text format     Abstract available


    March 2018
  5. DISNEY-HOGG L, Sud A, Law PJ, Cornish AJ, et al
    Influence of obesity-related risk factors in the aetiology of glioma.
    Br J Cancer. 2018 Mar 13. pii: 10.1038/s41416-018-0009.
    PubMed     Text format     Abstract available


    January 2018
  6. ZHANG W, Duan R, Zhang J, Cheung WKC, et al
    H1/pHGFK1 nanoparticles exert anti-tumoural and radiosensitising effects by inhibition of MET in glioblastoma.
    Br J Cancer. 2018 Jan 18. pii: bjc2017461. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


  7. HOTTINGER AF, Ben Aissa A, Espeli V, Squiban D, et al
    Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma.
    Br J Cancer. 2018 Jan 9. pii: bjc2017469. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    October 2017
  8. YU CF, Chen FH, Lu MH, Hong JH, et al
    Dual roles of tumour cells-derived matrix metalloproteinase 2 on brain tumour growth and invasion.
    Br J Cancer. 2017 Oct 24. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    September 2017
  9. TAY RY, Blackley E, McLean C, Moore M, et al
    Successful use of equine anti-thymocyte globulin (ATGAM) for fulminant myocarditis secondary to nivolumab therapy.
    Br J Cancer. 2017;117:921-924.
    PubMed     Text format     Abstract available


  10. BENKE G, Turner MC, Fleming S, Figuerola J, et al
    Occupational solvent exposure and risk of glioma in the INTEROCC study.
    Br J Cancer. 2017 Sep 14. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


  11. KLIMOV S, Rida PC, Aleskandarany MA, Green AR, et al
    Novel immunohistochemistry-based signatures to predict metastatic site of triple-negative breast cancers.
    Br J Cancer. 2017;117:826-834.
    PubMed     Text format     Abstract available


    August 2017
  12. ITO S, Koso H, Sakamoto K, Watanabe S, et al
    RNA helicase DHX15 acts as a tumour suppressor in glioma.
    Br J Cancer. 2017 Aug 22. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


  13. ABDUL RAHIM SA, Dirkse A, Oudin A, Schuster A, et al
    Regulation of hypoxia-induced autophagy in glioblastoma involves ATG9A.
    Br J Cancer. 2017 Aug 10. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


  14. SHI C, Ren L, Sun C, Yu L, et al
    miR-29a/b/c function as invasion suppressors for gliomas by targeting CDC42 and predict the prognosis of patients.
    Br J Cancer. 2017 Aug 8. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


  15. ADLER NR, Wolfe R, Kelly JW, Haydon A, et al
    Tumour mutation status and sites of metastasis in patients with cutaneous melanoma.
    Br J Cancer. 2017 Aug 8. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    June 2017
  16. MACIACZYK D, Picard D, Zhao L, Koch K, et al
    CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells.
    Br J Cancer. 2017 Jun 1. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    May 2017
  17. PARAKH S, Park JJ, Mendis S, Rai R, et al
    Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases.
    Br J Cancer. 2017;116.
    PubMed     Text format     Abstract available


  18. DONG Z, Lei Q, Yang R, Zhu S, et al
    Inhibition of neurotensin receptor 1 induces intrinsic apoptosis via let-7a-3p/Bcl-w axis in glioblastoma.
    Br J Cancer. 2017 May 11. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    March 2017
  19. HAN S, Meng L, Jiang Y, Cheng W, et al
    Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling.
    Br J Cancer. 2017 Mar 30. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


  20. JOHANSEN C, Schuz J, Andreasen AS, Dalton SO, et al
    Study designs may influence results: the problems with questionnaire-based case-control studies on the epidemiology of glioma.
    Br J Cancer. 2017 Mar 7. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


  21. KINSLER VA, O'Hare P, Jacques T, Hargrave D, et al
    MEK inhibition appears to improve symptom control in primary NRAS-driven CNS melanoma in children.
    Br J Cancer. 2017 Mar 2. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    January 2017
  22. ANDERSEN KK, Duun-Henriksen AK, Frederiksen MH, Winther JF, et al
    Ninth grade school performance in Danish childhood cancer survivors.
    Br J Cancer. 2017;116:398-404.
    PubMed     Text format     Abstract available


    November 2016
  23. LLAGUNO SR, Parada LF
    Cell of origin of glioma: biological and clinical implications.
    Br J Cancer. 2016 Nov 10. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


    October 2016
  24. WILLIAMS M, Treasure P, Greenberg D, Brodbelt A, et al
    Surgeon volume and 30 day mortality for brain tumours in England.
    Br J Cancer. 2016 Oct 20. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


  25. GUPTA A, Roberts C, Tysoe F, Goff M, et al
    RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases - results and lessons learnt.
    Br J Cancer. 2016 Oct 6. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: